日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial

巴尔西尼酮和达格列净治疗慢性肾脏病的疗效和安全性：MIRO-CKD试验的设计和基线特征

期刊:Nephrology Dialysis Transplantation
影响因子:5.6
doi:10.1093/ndt/gfaf119
Mark, Patrick B; De Sousa-Amorim, Erika; Eriksson, Anna L; Leonsson-Zachrisson, Maria; Guzman, Nicolas J; Miller, Matthew T; Jiang, Yunyun; Heerspink, Hiddo J L
发表日期：2025
文献求助 收藏

The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of balcinrenone

严重肾功能损害对巴尔西尼酮的药代动力学、安全性和耐受性的影响

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1002/bcp.70017
Bhattacharya, Chandrali S; Ericsson, Hans; Johansson, Susanne; Parkinson, Joanna; Boca, Simina M; Yang, Ye; Heijer, Maria; Housler, Greggory; Leonsson-Zachrisson, Maria; Hartleib-Geschwindner, Judith; Pizzato, Patricia Ely
发表日期：2025
文献求助 收藏

YINGLONG: A Multicenter, Prospective, Non-Interventional Study Evaluating the Safety and Tolerability of Ticagrelor in Chinese Patients with Acute Coronary Syndrome

英龙：一项多中心、前瞻性、非干预性研究，评估替格瑞洛在中国急性冠脉综合征患者中的安全性和耐受性

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-019-00972-z
Du, Xin; Zheng, Yang; Yang, Ping; Ma, Shuren; Yu, Zaixin; Su, Xi; Ge, Junbo; Leonsson-Zachrisson, Maria; Wang, Xianhong; Sun, Jing; Bai, Lu; Ma, Chang-Sheng
发表日期：2019
文献求助 收藏

Ticagrelor does not impact patient-reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study

替格瑞洛对镰状细胞病年轻成人患者报告的疼痛无影响：一项多中心、随机 IIb 期研究

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.15646
Kanter, Julie; Abboud, Miguel R; Kaya, Banu; Nduba, Videlis; Amilon, Carl; Gottfridsson, Christer; Rensfeldt, Martin; Leonsson-Zachrisson, Maria
细胞生物学
发表日期：2019
文献求助 收藏

Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study

替格瑞洛治疗中国急性冠脉综合征患者的安全性和心血管事件发生率：一项为期12个月的IV期多中心单臂DAYU研究

期刊:Cardiovascular Drugs and Therapy
影响因子:3.1
doi:10.1007/s10557-018-6772-3
Gao, Runlin; Wu, Yongjian; Liu, Hengliang; Su, Guohai; Yuan, Zuyi; Zhang, Aidong; Wang, Yong; Wang, Zhirong; Wang, Yan; Zhang, Huanyi; Zheng, Yang; Liu, Lei; Shen, Lijun; Leonsson-Zachrisson, Maria; Han, Yaling
发表日期：2018
文献求助 收藏

Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis

替那帕诺对接受血液透析患者血清磷酸盐的影响

期刊:Journal of the American Society of Nephrology
影响因子:9.4
doi:10.1681/ASN.2016080855
Block, Geoffrey A; Rosenbaum, David P; Leonsson-Zachrisson, Maria; Åstrand, Magnus; Johansson, Susanne; Knutsson, Mikael; Langkilde, Anna Maria; Chertow, Glenn M
发表日期：2017
文献求助 收藏

A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers

一项针对健康日本志愿者的替那帕诺安全性、耐受性、药效学和药代动力学的I期研究

期刊:Clinical and Experimental Nephrology
影响因子:1.7
doi:10.1007/s10157-016-1302-8
Johansson, Susanne; Rosenbaum, David P; Knutsson, Mikael; Leonsson-Zachrisson, Maria
发表日期：2017
文献求助 收藏

Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis

替那帕诺对血液透析患者透析间期体重增加的影响

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.09050815
Block, Geoffrey A; Rosenbaum, David P; Leonsson-Zachrisson, Maria; Stefansson, Bergur V; Rydén-Bergsten, Tina; Greasley, Peter J; Johansson, Susanne A; Knutsson, Mikael; Carlsson, Björn C
发表日期：2016
文献求助 收藏